Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser
The U.S. Food and Drug Administration (FDA) has taken action against a new type of drug advertiser, including the online provider Hims & Hers. The regulators sent around 100 warning letters this week to various drug advertisers, addressing concerns about their promotional practices. The FDA's focus is on the marketing and sale of weight-loss drugs, which are typically prescribed medications. The agency is concerned about the way these drugs are being advertised and sold, particularly through online platforms like Hims & Hers. The warning letters highlight the FDA's efforts to regulate the emerging digital health industry and ensure that consumers receive accurate and truthful information about prescription drugs. The agency is working to ensure that drug advertisers comply with the relevant laws and regulations, and that they do not make unsubstantiated claims or engage in misleading practices.
Source: For the complete article, please visit the original source link below.
